Salofa
Salofa is a Finnish private health-technology company that designs, manufactures, and distributes lateral flow and immunodiagnostic IVD products — including customizable drug tests, StrepA, FOB, CT Lines, BlueGreenTest, and a consumer self-test — for healthcare professionals, consumers, and veterinary end markets.
- Company typePrivate
- Founded2013
- HeadquartersSalo, Finland
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Salofa does
Salofa is a Finnish private health technology company (Salofa Oy) founded in 2013 in Salo, Finland, where it operates its own factory, warehouse, and headquarters. The company specializes in lateral flow and other immunodiagnostic technologies and manufactures in vitro diagnostic (IVD) products and medical devices. Its portfolio is organized into Professional Use products (DOA customizable drug tests detecting up to 16 substances from 30+ parameters, StrepA rapid tests, FOB fecal occult blood tests, and CE-marked CT Patient Lines and CT Filling Sets), Consumer/Consumables (BlueGreenTest® cyanobacteria hepatotoxin test and SALCARE® substance abuse self-test), Veterinary Diagnostics (Salvet infection tests and Removeo drug/liquid dispenser), and a Contract Manufacturing plus R&D service line that performs OEM/white-label work for partner brands.
The company's revenue model combines one-time unit sales of diagnostic kits and CT tubing with contract manufacturing and OEM licensing for healthcare and pharmaceutical clients. It distributes through direct B2B sales ([email protected]), a Finland-based reseller/distributor network, and consumer products via well-equipped pharmacies and retail outlets, while exhibiting internationally at trade shows such as Medica (Düsseldorf) and Medlab Middle East (Dubai). It holds ISO 13485:2016 certification (valid 2025-2027), CE conformity for CT Lines, and the Avainlippu (Key Flag) trademark (valid to December 31, 2027), selling to hospitals, clinics, laboratories, pharmaceutical companies, veterinarians, and end consumers.
Salofa employs 11-50 people and operates with a headcount-constrained, owner-style structure. Its strategic emphasis is on leveraging Finnish manufacturing to provide fast, certified supply of specialized IVD products that were previously constrained by foreign-sourced availability issues, while selectively expanding into consumer self-testing, veterinary diagnostics, and contract manufacturing for international brand partners (e.g., Bellylabs).
Salofa firmographics
Firmographics- Name
- Salofa
- Legal name
- Salofa Oy
- Website
- https://salofa.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Salofa is a Finnish private health-technology company that designs, manufactures, and distributes lateral flow and immunodiagnostic IVD products — including customizable drug tests, StrepA, FOB, CT Lines, BlueGreenTest, and a consumer self-test — for healthcare professionals, consumers, and veterinary end markets.
- Ownership category
- akta.pro rank
Salofa industry classification
Industry- Product category
- In Vitro Diagnostics (IVD)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)
- akta.pro secondary industry
- Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)
Keywords
Where Salofa is headquartered
LocationHeadquarters
- HQ city
- Salo
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
Salofa business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- IVD Products Sales: Sale of rapid diagnostic tests including DOA drug tests, StrepA tests, FOB tests, and BlueGreenTest to healthcare professionals and consumers
- CT Medical Tubing Products: Sale of CT Patient Lines and CT Filling Sets for intravenous therapy and contrast media administration in healthcare settings
- Contract Manufacturing Services: Full-service contract manufacturing from design and development to final production, serving pharmaceutical companies and healthcare providers with flexible solutions for any project scale
- OEM/White Label Solutions: Ready-made products that can be branded and marketed under client names, enabling companies to expand product lines with high-quality, reliable devices
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | DOA Rapid Drug Tests - 25 tests per pack |
| Unit Pricing | Pay-as-you-go | FOB Rapid Tests - 40 tests per pack |
| Unit Pricing | Pay-as-you-go | StrepA Tests - 25 tests per jar |
| Unit Pricing | Pay-as-you-go | BlueGreenTest - 1 or 3 tests per pack |
| Unit Pricing | Pay-as-you-go | SALCARE Consumer Drug Test - 1 test per pack |
| Unit Pricing | Pay-as-you-go | CT Patient and Filling Lines - Multiple configurations |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Salofa product offering
Product offeringCore offering
Salofa manufactures and markets in vitro diagnostic (IVD) rapid tests and medical devices built on lateral flow and immunodiagnostic technologies, including DOA drug tests, StrepA and FOB infection tests, CT patient and filling lines, cyanobacteria detection (BlueGreenTest), and a consumer substance abuse self-test (SALCARE), plus the Removeo veterinary dispenser. Beyond own-brand products, Salofa provides integrated OEM, white-label, contract manufacturing, and R&D services for pharmaceutical companies and healthcare providers. All manufacturing is conducted in the company's own factory in Salo, Finland under ISO 13485:2016 quality management.
Product overview
Salofa is a Finnish health technology company specializing in lateral flow and immunodiagnostic technologies. The company manufactures high-quality IVD (in vitro diagnostic) products and medical devices. The product portfolio is organized into four main categories: Professional Use products (DOA Rapid Drug Tests, StrepA Blueline Rapid Test, FOB Rapid Test, CT Patient Lines and Filling Sets), Consumables (BlueGreenTest® for cyanobacteria detection, SALCARE® substance abuse self-test for consumers), and Veterinary Diagnostics (Removeo drug dispenser). Additionally, Salofa offers Contract Manufacturing and R&D services as part of an integrated OEM, contract manufacturing, and research & development service model. All products are manufactured in the company's own factory in Salo, Finland.
Differentiator
Problem solved
Functional benefit
Brands
- SALCARE: Consumer-focused rapid substance abuse test brand for self-testing, detecting 12 intoxicating substances in urine.
- BlueGreenTest
- Salvet
- Removeo
Products and services
- DOA Rapid Drug Tests Rapid substance abuse and drug tests for professional use, including urine drug tests, manipulation tests, and saliva tests. Tests can detect up to 16 substances selected from over 30 parameters in a single cassette, with results available in 5 minutes. Sold in packs of 25 tests.
- StrepA Blueline Rapid Test Rapid chromatographic immunoassay for the qualitative detection of Streptococcus A in throat swab samples, intended as an aid in diagnosing group A streptococcal infection. Sold in jars of 25 tests with extraction tubes, reagents, and controls included.
- FOB Rapid Test Immunochromatographic in vitro diagnostic test for the rapid detection of human hemoglobin in feces, used to facilitate diagnosis of lower gastrointestinal disorders and support colorectal cancer screening. Sold in packs of 40 tests.
- CT Patient Lines and CT Filling Sets Sterile single-use intravenous lines for CT scans and MRI procedures. CT Patient Lines ensure patient safety when using contrast media syringes; CT Filling Sets enable safe refilling of CT syringes. Compatible with automatic contrast injectors at 300–350 psi, available in lengths from 20 cm to 120 cm.
- BlueGreenTest Cyanobacteria Test Single-use rapid test for detection of blue-green algae (cyanobacteria) hepatotoxins in recreational water, detecting over 90 microcystins and 10 nodularins. Results readable in 8 minutes after sample collection. Available in packs of 1 or 3 tests for consumers and professionals.
- SALCARE Substance Abuse Self-Test Consumer-facing rapid drug test designed to detect use of 12 intoxicating substances (10 drugs, alcohol, and tobacco products) in human urine, with results in 5 minutes. Distributed through Finnish pharmacies for at-home self-testing.
- Removeo Drug and Liquid Dispenser Veterinary medicine and liquid dispenser for administering medications and solutions to animals. Includes a 30 ml container, dispenser, and suction part, simplifying dosing even for difficult-to-handle animals.
- Contract Manufacturing Services End-to-end contract manufacturing covering design, development, and final production. Includes OEM (Original Equipment Manufacturing) and white-label solutions for pharmaceutical companies and healthcare providers, with flexible project scale and full lifecycle support.
- Research & Development Services Comprehensive R&D services for immunodiagnostic innovations including concept development, prototyping, testing and validation, product optimization, and transition to final production. Specializes in lateral flow and immunodiagnostic technologies for partner products.
- Bellylabs Pregnancy Test for Dogs (Contract Manufactured) World's first home pregnancy test for dogs, manufactured by Salofa on a contract basis for Bellylabs. Developed from initial R&D through final production, meeting high quality and reliability standards for the pet care market.
Quantifiable outcome
- Deliveries within Finland and Europe
- +2 more outcomes
Companies that use Salofa
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles5 records
Salofa technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Salofa partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Tukikohta rycorePartnership with Tukikohta ry (Finnish harm reduction organization) for drug testing services and prevention of drug-related deaths. The collaboration enables comprehensive approach to drug death prevention, offering broader support for young people and their families in early identification of substance abuse problems and access to treatment services.
- BellylabscoreContract manufacturing partnership resulting in the world's first home pregnancy test for dogs. Salofa worked with Bellylabs from initial R&D stages through final production, ensuring high quality and reliability standards were met for the innovative pet care product.
- MekalasiminorFinnish distributor for Salofa's CT Lines products in Finland. Mekalasi (www.mekalasi.fi) distributes CT Patient Lines and CT Filling Sets to healthcare facilities.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Salofa competitors and assessment
Company assessmentBroad incumbents
- bioMérieux SA: Global French in vitro diagnostics leader with broad microbiology, immunoassay and industrial testing portfolios. Although focused on lab-based diagnostics, it sets the competitive bar in European IVD against which Salofa's lateral-flow offerings are evaluated by hospital procurement.
- Meridian Bioscience, Inc. Established US-headquartered diagnostics company with a strong rapid-test and lateral-flow portfolio spanning infectious disease, food and clinical diagnostics. A broader incumbent whose lateral-flow DOA and IVD franchise overlaps substantially with Salofa's product lines.
- QuidelOrtho Corporation: Large US diagnostics platform combining Quidel's rapid lateral-flow tests with Ortho's clinical chemistry/immunoassay franchise. Competes with Salofa across rapid IVD and lateral-flow testing in professional settings, though at materially greater scale and breadth.
Direct peers
- Securetec Detektions-Systeme AG: German specialist in saliva-based and lateral-flow drug-of-abuse rapid tests with comparable R&D depth and CE-marked European positioning. Comparable to Salofa in DOA configuration and substance coverage, as well as European professional-channel sales.
- nal von minden GmbH: German manufacturer of lateral-flow drug-of-abuse tests, multi-drug cassettes, and rapid IVD tests with comparable configurability and CE-IVD positioning. Highly comparable to Salofa given similar product architecture, EU regulatory backbone, and OEM/CDMO services model.
- ACON Laboratories, Inc. US/global manufacturer of lateral-flow rapid diagnostics for drugs of abuse, infectious diseases, fertility and cardiac markers with extensive OEM/white-label capabilities. Closely comparable scale, product mix and OEM business model to Salofa.
- BTNX Inc. Canadian manufacturer of rapid lateral-flow diagnostic kits including multi-drug DOA cassettes, infectious disease tests and fertility tests sold globally to professional and consumer channels. Directly competes with Salofa across DOA drug tests and contract/OEM services.
- Hangzhou AllTest Biotech Co., Ltd. China-based manufacturer of lateral-flow rapid diagnostic tests spanning infectious disease, drugs of abuse, pregnancy and cardiac markers. Material competitor to Salofa on DOA cassettes and broader IVD test kits through OEM/private-label channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Salofa social profiles
Digital presenceSalofa compliance and trust
Trust signalCompliance3 records
Salofa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Salofa leadership team
Management profileNumber of profiles
Profiles4 records
Salofa funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Salofa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Salofa
What does Salofa do?
Salofa manufactures and markets in vitro diagnostic (IVD) rapid tests and medical devices built on lateral flow and immunodiagnostic technologies, including DOA drug tests, StrepA and FOB infection tests, CT patient and filling lines, cyanobacteria detection (BlueGreenTest), and a consumer substance abuse self-test (SALCARE), plus the Removeo veterinary dispenser. Beyond own-brand products, Salofa provides integrated OEM, white-label, contract manufacturing, and R&D services for pharmaceutical companies and healthcare providers. All manufacturing is conducted in the company's own factory in Salo, Finland under ISO 13485:2016 quality management.
Is Salofa a public or private company?
Salofa is a private company. It is classified as unknown and is currently operating.
When was Salofa founded?
Salofa was founded in 2013. It employs 11 to 50 people.
Where is Salofa based?
Salofa is headquartered in Salo, Finland, in the Europe region.
How does Salofa make money?
Four revenue lines are on record. IVD Products Sales are the primary driver. The others are CT Medical Tubing Products, contract Manufacturing Services and OEM/White Label Solutions.
Who are Salofa's main competitors?
Broad incumbents on record are bioMérieux SA, Meridian Bioscience, Inc. and QuidelOrtho Corporation. Direct peers are Securetec Detektions-Systeme AG, nal von minden GmbH, ACON Laboratories, Inc., BTNX Inc. and Hangzhou AllTest Biotech Co., Ltd..
Does Salofa have an API?
No public API is recorded for Salofa.
What industry is Salofa in?
Salofa's product category is In Vitro Diagnostics (IVD). Its primary akta.pro industry code is IMALAIAF, Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes), with a secondary code of HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services. Its NAICS code is 325413 and its SIC code is 2835.